An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

Cervical cancer is the third most common gynecological cancer in the United States, but a Louisville doctor says it can be ...

The U.S. Preventative Services Task Force is updating HPV and cervical cancer testing guidelines for women. Posted: January ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

By the time adolescents reach late teens or early 20s, it is often too late to impart critical knowledge about prevention, ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

A cervical cancer screening - which used to be known as a 'smear test' - is available for women and anyone with a cervix ...

Dr Neerja Bhatla, a renowned figure in obstetrics and gynaecology, has been honored with the Padma Shri for her pioneering work in cervical cancer detection and prevention. Over the past 35 years, she ...

Cervical cancer is one of the leading causes of cancer-related deaths among women worldwide. Despite being preventable and treatable when detected early, many w ...